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SYNAPTIC NEUROSCIENCE
severe abnormalities in synaptic function can precede neuronal 
loss and even NFTs formation (LaFerla et al., 2007; Yoshiyama 
et al., 2007). While the molecular mechanisms responsible for this 
early malfunction (as well as those responsible for tau polymeri-
zation dependent pathogenesis) remain unknown (Marx, 2007). 
Neurofibrillary degeneration is accompanied by lysosomal hyper-
trophy (Nixon et al., 1992), beading and degeneration of distal den-
drites (Braak et al., 1994; Marx, 2007) and axonal damage (Kowall 
and Kosik, 1987).
In the present study physiological concentrations of recom-
binant human tau isoform (full length h-tau42; Perez et al., 2001) 
was directly injected into the presynaptic terminal of the squid 
giant synapse, to examine possible acute effects of h-tau on the 
synaptic release mechanism. The results showed that heavy exog-
enous h-tau42 accumulation induces a rapid and short-lasting 
increase in spontaneous transmitter release followed by a drastic 
decrease and failure of synaptic transmission. This synaptic block 
does not affect presynaptic calcium current flow or spike generation 
at the presynaptic terminal. Immunohistochemistry, performed 
in h-tau42 injected synapses, demonstrated that h-tau42 becomes 
phosphorylated rapidly in good temporal agreement with the time 
course of the transmitter failure. Electron microscopy and electro-
physiological experiments unambiguously indicate that h-tau42-
mediated synaptic transmission block is due to exocytosis failure. 
IntroductIon
Classical neuropathological studies characterized the intracel-
lular accumulation and aggregation of abnormal filaments com-
posed primarily of the microtubule associated protein tau as a 
hallmark for a variety of neurodegenerative disorders known as 
tauopathies, as exemplified by progressive supranuclear palsy, 
Pick’s disease, corticobasal degeneration, and frontotemporal 
dementia with Parkinsonism linked to chromosome 17 (FTDP-
17; Lee et al., 2001). The most common tauopathy, Alzheimer’s 
disease (AD), is also characterized by additional filamentous 
structures paired helical filaments (PHFs) and straight fila-
ments (SFs). These filaments eventually form large aggregations, 
known as neurofibrillary tangles (NFTs). In addition, diffuse 
and mature senile plaques, which are predominantly composed 
of amyloid beta (Aβ) peptides, are present in AD brains too 
(Selkoe, 2001).
A number of studies have investigated the role of different forms 
of Aβ peptides and aggregates in synaptic function (Arancio et al., 
2004; Moreno et al., 2009), but so far the role of tau or tau aggregates 
in neurotransmission has not been elucidated.
The association between tau filaments, neuron loss, and brain 
dysfunction in vertebrates and invertebrates originally led to the 
hypothesis that NFTs invariably cause brain dysfunction and neu-
rodegeneration. However, mouse tauopathy studies indicate that 
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Finally, systemic administration of the novel compound T-817MA 
prevented the structural, biochemical, and functional deleterious 
effects h-tau42 microinjection.
The present set of studies identifies several mechanisms of tau-
mediated toxicity at the presynaptic terminal, and introduces a 
potential disease modifier for AD and other tauopathies for which 
there is no specific treatment presently.
MaterIals and Methods
tau proteIns
Recombinant human tau, h-tau42 (isoform with four tubulin bind-
ing motifs and two extra exons in the N-terminal domain) was 
isolated as previously described (Perez et al., 2001).
IMMunohIstocheMIstry
A variation of the array tomography method by Micheva and Smith 
(2007) was followed. The ganglia were fixed by immersion in 4% 
paraformaldehyde (EM grade EM Sciences) plus 7.0% sucrose in 
calcium-free sea water for 3 h; rinsed with 7 % sucrose and 50 mM 
glycine in 0.1 M PBS; dehydrated with graded ethanol dilutions 
(50%, 70%, 90%, and 3× 100%), embedded in LR White resin 
(medium grade, SPI), and polymerized in gelatin capsules at 49°C 
for 48 h. Semithin sections (500 nm) were mounted on subbed slides 
and encircled on the slides with a PAP pen (EM Sciences, USA). The 
immunocytochemistry was done as follows: (a) blocked in 50 mM 
glycine in tris buffer pH 7.6, 5 min; (b) primary antibody incuba-
tion, anti-tau PHF (AT8, Thermoscientific, USA) diluted 1:50 in 
1% BSA in tris (tris-BSA), 4 h; (c) rinses in tris-BSA 2× 5 min: (d) 
secondary antibody incubation, goat anti-mouse Alexa Fluor 594 
diluted 1:150 in tris-BSA, 30 min; (e) tris and distilled water rinses, 
4× 5 min each; (f) mounting of slides with coverslips and anti-
fading mounting media; (g) image under fluorescent microscopy 
(Zeiss Axioimager, Germany). Controls were performed with the 
same protocol omitting the primary antibody. Primary antibody: 
Anti-tau PHF (AT8; Thermoscientific, USA), secondary antibody: 
Alexa Fluor 594 goat anti-mouse (Invitrogen).
t-817Ma adMInIstratIon
Squid received an oral dose of T-817MA (0.25 ml of 3.68 mmol l−1 
T-817AM) every 12 h using a methodology recently developed by 
our group (Berk et al., 2009). At 24 h after the first dose a second 
dose was given, and the electrophysiological experiments were per-
formed 1 h after the second feeding. The optimal dose, absorp-
tion, and concentration reached in the optic lobes of T-817MA 
in squid had been obtained previously (Berk et al., 2009). Indeed, 
it was determine that after 24 h of the double administration, a 
T817-MA concentration of 26.7 μmol 1−1 was measured in the CNS 
of the gastrically intubated squid (n = 10 squid). Synapses from 
T-817MA-treated squid were microinjected at the presynaptic axon 
with h-tau42 (an approximate 80 nM final concentration h-tau42 
(n = 19), considering a 100× dilution factor. Pre- and post-synaptic 
potentials were recorded for 90 min.
electrophysIology and MIcroInjectIons
The squid (Loligo paelli) stellate ganglia isolation from the mantle 
and the electrophysiological techniques used have been described 
previously (Llinas et al., 1985). Two glass micropipette electrodes 
impaled the largest (most distal) presynaptic terminal digit at the 
synaptic junction site while the post-synaptic axon was impaled by 
one microelectrode at the junctional site. One of the pre-electrodes 
was used for pressure microinjection of h-Tau 42 and also sup-
ported voltage clamp current feedback, while the second monitored 
membrane potential. The total volume injected fluctuated between 
0.1 and 1 pl. (Llinas et al., 1985). The exact location of injection 
and the diffusion and steady-state distribution of the protein/flu-
orescent dye mix (0.001% dextran fluorescein) were monitored 
using a fluorescence microscope attached to a Hamamatsu cam-
era system (Middlesex, NJ). In all experiments a good correlation 
was observed between the localization of the fluorescence and the 
 electrophysiological findings.
electron MIcroscopy
Immediately following the electrophysiological study the ganglia 
were removed from the recording chamber, fixed by immersion in 
glutaraldehyde, post-fixed in osmium tetroxide, stained in block 
with uranium acetate, dehydrated and embedded in resin (Embed 
812, EM Sciences). Ultrathin sections were collected on Pioloform 
(Ted Pella, Redding, CA) and carbon-coated single sloth grids, 
and contrasted with uranyl acetate and lead citrate. Morphometry 
and quantitative analysis of the synaptic vesicles were performed 
with the in house program developed with LabVIEW (National 
Instruments, Ostin, TX, USA). Electron micrographs were taken 
at an initial magnification of ×16,000 and ×31,500 and photo-
graphically enlarged to a magnification of ×40,000 and ×79,000 
for synaptic vesicles and clathrin-coated vesicle (CCV) counting, 
respectively. Vesicle density at the synaptic active zones was deter-
mined as the number of vesicles per μm2, on an average area of 
0.8 μm2 per active zone. CCV density was determined within the 
limits of the presynaptic terminal on an average terminal area of 
3.3 μm2.
pharMacologIcal tools
T-817MA (1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}azeti-
din-3-ol maleate), was synthesized at Toyama Chemical Co. Ltd., 
Japan.
results
Intra-axonal h-tau42 acutely blocks synaptIc transMIssIon
Following presynaptic and post-synaptic axon impalements 
and the determination of normal synaptic transmission (Llinas 
et al., 1985, 1994; Lin et al., 1990), the effect of human tau on 
synaptic release was evaluated by presynaptic microinjections 
administered under direct visualization using a fluorescent dye/
protein mix, reaching a final concentration after diffusion of 
approximately 80 nM (see Materials and Methods). Presynaptic 
and post-synaptic potentials were recorded simultaneously under 
current-clamp configuration. Presynaptic spikes were activated 
every 5 min (low-frequency protocol). With this paradigm, it 
was determined that 5–10 min after an injection of h-tau42, a 
reduction of transmitter release could be observed. With further 
time, a total block of transmission resulted, within 30–40 min 
depending on the length of the release zone in the preterminal 
axon (Figures 1A and 2 blue dots, n = 8). No modification of 
presynaptic spike amplitude or duration ensued (Figure 1A). 
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Figure 2 light brown dots, n = 4) which initially generated post-
synaptic repetitive activation (Figure 1C, Post 1). This train stimu-
lation was repeated once a minute until post-synaptic spike failure 
occurred from the first stimulus in the train. Note that the ampli-
tude of the subthreshold synaptic potentials showed little reduction 
during the stimulus train itself but steadily reduced in amplitude as 
h-tau42 mobilizes into the preterminal. The fact that the amplitude 
of the evoked post-synaptic potentials remained unchanged dur-
ing the duration of a given repetitive stimulation barrage indicates 
that the limiting factor was the vesicular release process (Figure 1C 
Post 2). This synaptic failure did not recuperate after 15 min of rest 
(as normally occur in this preparation; Llinas et al., 1985, 1994; 
Lin et al., 1990), but rather diminished to just noticeable ampli-
tude (Post 3). In synapses from squid pretreated with T-817MA, 
microinjection with h-tau42 (Figures 1D and 2, green dots 
n =  6), show the normal reduction of the EPSP amplitude dur-
ing the repetitive stimulus barrage, however, the treated animals 
showed normal recovery after a 15-min rest period. These find-
ings indicate that T-817MA administration results in the normal 
recovery of synaptic transmission after high frequency stimulation, 
suggesting that the h-tau 42 effects could relate to vesicular avail-
ability and not to the actual vesicular release process (Figure 1D 
Post 3 and Figure 2, green dot, n = 5).
By contrast,  following T-817MA administration to the squid 
(see bellow) h-tau42-dependent transmitter block was prevented 
(Figures 1B and 2 red dots, n = 7).
To determine whether the transmission block described above 
was produced by a reduction of transmitter availability (as would 
be expected by inhibition of any step in the synaptic vesicle recy-
cling pathway, e.g., endocytosis, refilling of vesicles with trans-
mitter, or docking.) or by a defect in synaptic vesicle fusion, the 
effect of trains of presynaptic high frequency stimuli (100 Hz) 
was tested. This form of activation rapidly depleted the transmit-
ter, as evidence by the rapid decrease in post-synaptic potential 
amplitude during a stimulus train (Figure 1D Post 2). The rapid 
time course of this decay has been shown to give an estimate of 
transmitter availability (Llinás et al., 1994), and is a reflection of 
a decrease in either synaptic vesicle mobilization or docking. On 
the other hand, synaptic block accompanied by a slow, progressive 
reduction of post-synaptic amplitude, without amplitude reduc-
tion during the tetanic stimulus, is a direct indication that the 
block is due to a defect in transmitter release (Llinás et al., 1994), 
i.e., vesicular fusion.
The test paradigm implemented to address this query consisted 
of synaptic high frequency (100 Hz) spike activation of the presyn-
aptic axon of synapses preinjected with h-tau42 (Figure 1C, 1 Pre 
Figure 1 | electrophysiological Findings following presynaptic h-tau42 
injection. (A) Pre- and post-synaptic potential following a direct electrical 
stimulation of the presynaptic axon. Synaptic transmission fails in 30 min 
following h-tau42 preinjection (six subsequent stimuli at 5-min intervals). 
(B) Similar experiment as in (A) (24 subsequent stimulus are shown at 5-min 
interval) following h-tau42 injection in a T-817MA-treated squid. Transmission 
block does not occur within the 2-h period. (C) Repetitive stimulation at 100 Hz 
following h-tau42 injection results in a step like decrease in post-synaptic 
response amplitude that slowly progresses (post 1,2,3) but shows small 
variation in amplitude during a given stimulus train. (D) Similar train stimulus 
paradigm produced reduction of transmitter release, which recuperated to the 
80% amplitude in 15 min (post 1, 2, and 3). (e) Power spectra of spontaneous 
post-synaptic noise. Noise recording at the post-synaptic terminal (upper and 
lower panels on the left) were taken at 1-min intervals following 
h-tau42preinjection. Spontaneous release as determined by synaptic noise 
power spectrum (right panel) in (e), showed rapid reduction within a 12-min 
interval (reading taken at a 1/minrate). (F) h-tau42 preinjection produces block of 
presynatic release (c) without affecting presynaptic inward calcium current (b). 
Preterminal voltage step were repeated every minutes. For further detail see 
text and Figure 2.
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of post-synaptic response amplitude, to total failure, without a 
change in the amplitude or time course of the presynaptic ICa2+ 
(Figure 1F). Under normal conditions this paradigm results in 
transmitter release that last, unaltered, for up to 2 h, the maximum 
period utilized (Llinas et al., 1985). The results show, therefore, 
that neither the time course nor the amplitudes of the presynaptic 
calcium currents were altered concomitantly with the transmitter 
release block induced by h-tau42 (Figures 1F and 2). The time 
course and number of electrophysiological experiments are sum-
marized in Figure 2.
Intra-axonal h-tau42 becoMes phosphorylated and produces 
synaptIc vesIcle aggregatIon
Since the aggregation of typical tau filaments is accompanied by the 
development of tau hyperphosphorylation, we investigated whether 
h-tau42 residues serine 202, threonine 205 and/or 231were phospho-
rylated in the squid synapse. We used AT8 antibodies, as commonly 
used in neuropathological studies (Goedert et al., 1995). Here, we 
used immunohistochemistry in a variance of the array tomography 
technique (Micheva and Smith, 2007); we found that single sections 
(500 nm) allowed a clear view of the pre- and post-synaptic com-
partments (Figure 3A). Anti-phospho-tau immunohistochemistry 
was detected as dot-like profiles in the presynaptic compartment in 
h-tau42 injected synapses but drastically reduced in T-817 treated 
squid (Figure 3B lower panel). These were absent in synapses injected 
with vehicle (Figure 3D lower panel). This finding demonstrates that 
h-tau42 becomes phosphorylated in the squid axon.
ultrastructural presynaptIc changes secondary to h-tau42 
InjectIon
The structural changes that follow h-tau42 injection were addressed 
by rapidly fixing stellate ganglia (see Materials and Methods) 
after high or low-frequency stimulation protocols. The material 
consisted of injected synapses (62 synaptic active zones from 10 
different squid) and vehicle-injected synapses (control, 27 active 
zones in five synapses). The synapses were fixed ∼75–90 min after 
h-tau42 injection and processed for ultrastructural microscopy 
(see Materials and Methods). There was a statistically significant 
reduction in the number of “docked vesicles” in h-tau42-injected 
synapses compared to axons injected with vehicle (Table 1). This 
reduction was not seen in T817MA-treated squid following h-tau42 
injection (Table 1).
As shown in representative control synapses (Figure 4A), vesi-
cles are normally present at the active zone, some in contact with 
the presynaptic terminal membrane (docked). By contrast, in 
h-tau42-injected synapses (Figure 4B) vesicles were often closely 
aggregated with electron dense material serving as a bonding 
matrix (red dot). Similar electron dense material was also observed 
around vesicles in contact with the active zone (red arrows). At 
a lower magnification (Figure 4C) a large number of aggregated 
vesicular profiles are evident in the vicinity of the active zone (red 
dots). In T-817MA administered squid, the synaptic morphol-
ogy was quite similar to the vehicle-injected synapses (compare 
Figures 4A,D). Quantification of number of undocked, docked, 
and clathrin-coated vesicles (CCV) among the three groups 
(control, h-tau42 injected, and h-tau42 injected + T-817MA) is 
tabulated in Table 1.
tau ModIfIes spontaneous neurotransMItter release and 
produces an early transIent Increase In Intracellular 
calcIuM
Beyond spike-initiated release, the possibility that h-tau42 may 
affect spontaneous transmitter release was directly evaluated using 
post-synaptic noise analysis. A detailed description of the tech-
nique has been published by our team (Lin et al., 1990). In all 
preparations tested (n = 6) the membrane noise recorded from 
the post-synaptic axon increased during the initial 5 ± 1 min after 
presynaptic microinjection of h-tau42, this was followed by rapid 
noise level reduction in parallel with decreased amplitude of the 
evoked transmitted release. An example of the time course of noise 
level changes is illustrated in Figure 1E (left panel and Figure 2 
purple dots n = 3). Note the biphasic changes in noise levels. A fre-
quency spectrum of the membrane noise at different times after the 
h-tau42 injection is shown in Figure 1E (right panel). This pattern 
indicates that block by h-tau42 interferes with both spontaneous 
and evoked transmitter release.
MechanIsMs underlyIng tau-Induced synaptIc block
Following the initial finding that transmission is rapidly blocked by 
h-tau42; the possibility that this block was associated with changes 
in presynaptic calcium currents (ICa2+) was tested. The amplitude 
and time course of ICa2+ (Figure 1F) were directly determined by 
presynaptic voltage clamp steps, after blocking voltage dependent 
K+ and Na+ currents (n = 6), as previously described (Llinas et al., 
1985). ICa2+ amplitude and time course were determined at 5-min 
intervals over a period of 25 min following presynaptic injection 
of h-tau42, 80 nM.
Voltage clamp experiments were implemented with presyn-
aptic voltage steps that generated presynaptic inward calcium 
current and post-synaptic EPSPs. Following h-tau42 injection 
presynaptic voltage steps were repeated at 5 min intervals (low-
frequency stimuli), which resulted in a progressive reduction 
Figure 2 | Time course of synaptic transmission reduction following 
presynaptic Tau injection. Single spike transmission, (blue circles n = 8), 
voltage clamp release (black circles, n = 4), post-synaptic spectral noise (purple 
circles n = 3) and repetitive presynaptic stimulation (brown circles n = 3) 
resulted in a rapid reduction of transmitter release without recovery after 15-min 
rest period. Parenteral T-817MA administration results in the block of h-tau42 
effect on transmitter release reduction (red circles n = 7) and in the recovery of 
synaptic transmission from train stimulation after 15-min rest period.
Moreno et al. h-tau mediated synaptic transmission failure
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prevented the h-tau42 dependent synaptic vesicle clustering, indicating 
a close relation between such morphology and the synaptic transmitter 
release block observed electrophysiologically. Finally squid pretreated 
with T-817MA showed a significantly reduced signal of intra-axonal 
h-tau42 phosphorylation, as detected by AT8 immunohistochemistry 
(Figure 3).
dIscussIon
While the underlying pathogenic mechanisms of tau related neu-
ronal abnormalities remain obscure, the acute effects of preter-
minal injection of h-tau42 presented here suggest that synaptic 
dysfunction is an early mechanism in AD and other tauopathies. 
We used the squid giant synapse in this study because it provides 
unique advantages in addressing the cellular and molecular mecha-
nisms involved in chemical synaptic transmission. In this set of 
experiments we determined that h-tau42 produces a rapid failure 
in exocytosis. Our results also indicate that h-tau42 has previ-
ously unknown physiological properties that may be relevant in 
tau related neurodegenerative process.
huMan tau-42 acutely blocks cheMIcal synaptIc 
transMIssIon wIthout affectIng the presynaptIc calcIuM 
currents or the endocytIc pathway
The data presented here indicate that an excess of h-tau42 pro-
tein produces synaptic transmission block by interfering with a 
mechanism of synaptic vesicle exocytosis. Our conclusion, that 
h-tau42 induces a failure in neurotransmitter availability due 
to reduced synaptic vesicle release, is derived from morphologi-
cal (Figures 4B,C), high frequency stimulation (Figure 1C), and 
 spontaneous neurotransmitter release data (Figure 1E). Moreover, 
all the h-tau-42 injected synapses demonstrated a drastic block of 
systeMIc adMInIstratIon of t-817Ma prevented tau-MedIated 
synaptIc block, synaptIc vesIcle aggregatIon, and decreased 
h-tau42 phosphorylatIon
T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}  azetidin-3-ol 
maleate) is a newly developed neuro-protective agent that prevents oxi-
dative stress, nitric oxide-induced neurotoxicity, and acts as a neuro-
trophic factor (Hirata et al., 2005). Although it has been shown that 
T-817MA administration may ameliorate amyloid beta related neuronal 
dysfunction (Nguyen et al., 2007; Kimura et al., 2009), its effect on tau 
related pathology is unknown. To study the potential effects of T-817MA 
on tau neuropathology, squids received an oral dose of T-817MA as 
described in the Section “Materials and Methods”. Electrophysiologi-
cally, as shown in Figure 1B no significant changes in the amplitude or 
time course of the pre- or post-synaptic potentials were observed. Fur-
ther, ultrastructural studies in synapses used for the electrophysiological 
experiments demonstrated the number of docked vesicles recovered to 
the normal range in h-tau42/T-817MA squid (31 active zones in six 
synapses; 10.0 ± 0.6) compared to control synapses (10.1 ± 0.7), with 
the presence of normal CCV profiles (3.9 ± 0.4). Also clear was a sig-
nificant  reduction, of  electron dense vesicles clusters and electron dense 
active zones (see Table 1; Figure 4). It is thus concluded that T-817MA 
Figure 3 | Presynaptic hyperphosphorylation immunohistochemistry. 
(A) Confocal image of the giant synapse showing the presynaptic terminal (Pre 
Terminal) and the post-synaptic axon (Post Terminal). The red line indicates plane 
of section for the images in (B), (C), and (D). (B) Light microscopical image of 
the two cross-sected giant axons showing the pre- and post-synaptic 
axoplasmic cytosol. Upper left panel (green): section of the synapse showing 
the presynaptic terminal (dark). Lower left panel: Fluorescence 
immunohistochemistry using AT8 antibodies, demonstrating h-tau42 
phosphorylation level (red). (C) Upper middle panel: Transected synapse in a 
T-817MA-treated squid (green). Lower middle panel: Immunohistochemistry 
demonstrating a highly reduced level of h-tau42 phosphorylation (red). (D) Upper 
right panel: Transected synapse, injected with vehicle, to serve as a control, 
using the same protocol as in (C). Lower panel immunohistochemical absence 
of h-tau42 phosphorylation in the h-tau42 uninjected synapse.
Table 1 | Quantification of preterminal docked vesicles in: control, 
h-tau42 injected and h-tau42 injected in T-817MA pretreated squid.
 undocked Clathrin-coated Docked
Control 67.3 ± 5.8 3.2 ± 0.4 10.1 ± 0.7
h-tau42 61.2 ± 3.3 4.3 ± 0.3 5.8 ± 0.4*
T817-MA + h-tau42 56.7 ± 3.5 3.9 ± 0.4 10.0 ± 0.6*
Number of vesicles in 1 μm2 of active zone, Average ± SEM, *p  0.001.
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tau is adversely affected by excess phosphorylation resulting in tau 
being displaced from microtubules and aggregating, which in turn 
leads to microtubule disassembly, disruption of axonal transport, 
and finally synaptic failure (Stamer et al., 2002).
Concerning cephalopods, it has been demonstrated that h-tau 
binds to the squid axonal microtubules, but monomeric h-tau did 
not affect fast axonal transport (FAT), while filamentous h-tau42 
did block anterograde FAT (LaPointe et al., 2009). However, other 
studies have found that flies misexpressing tau show defects in neu-
ronal traffic without evidence of tau aggregation (Jackson et al., 
2002; Mudher et al., 2004). Finally, extracellular applied h-tau42 
to cell cultures produced aberrant signaling through muscarinic 
receptor activation (Gomez-Ramos et al., 2008; Diaz-Hernandez 
et al., 2010), suggesting that even “normal” tau may be detrimen-
tal when its expression becomes elevated or when it accumulates 
extracellularly. From these observations, it appears that an optimal 
level of tau phosphorylation is required to achieve the balance in 
the level of “free” and “microtubule bound” tau that is essential 
in maintaining microtubule dynamics and subsequent axonal 
transport.
As in the experiments mentioned above, in our experiments 
h-tau42 also became phosphorylated in the isolated axon (separated 
from the cell body) as demonstrated by immunohistochemistry 
using AT8 antibodies (Figure 3B). AT8 recognizes epitopes phos-
phorylated by GSK3 and cdk5 kinases both of which are found 
in squid axoplasm (Takahashi et al., 1995; Morfini et al., 2002; 
Hanger et al., 2009), suggesting that either one or both kinases 
may be involved in the effects of h-tau42 in the presynaptic ter-
minal. Whichever the specific kinase, the results demonstrate that 
isolated axons have the complete machinery to produce local post 
both spontaneous and evoked transmitted release, without affecting 
presynaptic spike generation (Figure 1A) or the associated calcium 
current (Figure 1F). We interpret these findings as reflecting the 
reduced vesicle count at the active zone, the vesicles being instead 
concentrated in groups away from the active zone. It was also noted 
that these electron dense vesicular congregations were character-
ized by profiles resembling vesicular adhesions to microfilaments 
as would be expected if synapsin 1 were to be dephosphorylated 
affording a strong adhesion to such microfilaments (Llinas et al., 
1985). As a result h-tau42 would lead to the failure in exocytosis 
due to both a defect in the release mechanism and a reduction in 
vesicular availability (Llinas et al., 1991).
huMan tau Is phosphorylated In the Isolated presynaptIc 
terMInal and Induces abnorMal vesIcular clusterIng
Previous experiments in drosophila have shown that misexpres-
sion of human – tau (h-tau), the same isoform as the one used in 
our experiments, produced significant neurodegeneration (Jackson 
et al., 2002; Avila et al., 2004; Steinhilb et al., 2007). In the drosophila 
model tau co-expressed with Shaggy, which generated a single fly 
homolog of GSK-3β, the phenotype was aggravated (Jackson et al., 
2002). Dysfunctional phenotypes were also found in the central 
neurons of lamprey, where long-term expression (2–38 days) of 
several h-tau isoforms produced neurodegenerative changes as a 
result of accumulation of h-hyperphosphorylated tau which cor-
related with the appearance of structures that resemble AD char-
acteristic – “straight like filaments” (Hall et al., 1997). In the latter 
experiments the isoform hyperphosphorylated moiety was, to a 
larger extent, the long form of h-tau (h-tau42; Hall et al., 1997; Lee 
et al., 2009). It has been proposed that the physiological function of 
Figure 4 | ultrastructure of the synaptic junction demonstrating 
differences in normal and h-tau42 injected synapses in untreated and 
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functional and biochemical h-tau42 induced abnormalities in the 
presynaptic axon are prevented/ameliorated by this compound is 
a fundamental initial step toward the identification of therapeutic 
candidates to treat tauopathies.
conclusIon
Our results indicate that h-tau42 affects synaptic release by modi-
fying intracellular phosphorylation homeostasis as a resultant of 
the h-tau42 hyperphosphorylation. This dynamic change, we pro-
pose, leads to a marked reduction of synaptic vesicle availability, 
most probably due to the reduction of synapsin 1 phosphoryla-
tion, known to be a powerful modulator of synaptic release (Llinas 
et al., 1985). Beyond affecting  synaptic release the reduction of 
such vesicular fusion on constitutive vesicular dynamics would also 
result in a disconnection event ultimately generating a “dying-back” 
phenomenon (Stamer et al., 2002; Pigino et al., 2007; Serulle et al., 
2007). Systemic administration of T-817MA, a proposed neuro-
protective agent, rescued tau-induced synaptic abnormalities, 
markedly reduced h-tau42 hyperphosphorylation and prevented 
synaptic vesicle clustering, as determine by ultrastructural analysis.
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 translational modifications and that these changes may explain, 
in part, the detrimental effects of excessive “normal tau” on the 
function of the presynaptic terminal.
Moreover, the vesicle clustering observed in h-tau42 injected 
synapses, resembled the effect of unphosphorylated synapsin 1 
on synaptic vesicle (Jackson et al., 2002). The fact that h-tau42 
is phosphorylated intra-axonally and that unphosphorylated syn-
apsin 1 restrains the vesicle pool to the cytoskeleton – producing a 
decreased number of vesicles available for exocytosis was actually 
demonstrated some time ago (Llinas et al., 1985).
A possible explanation of our findings is that h-tau42 induces 
changes in the balance of kinases and phosphatases, perhaps 
influenced by the concentration of h-tau aggregates. We hypoth-
esize that this could decrease the phosphorylated/dephospho-
rylated ratio in proteins involved in synaptic vesicle function, 
such as synapsin 1, which would result in a reduction in the 
available vesicles and ultimately synaptic transmission failure. 
Tau is phosphorylated by several protein kinases and this is bal-
anced by protein phosphatases dephosphorylation. The potential 
kinases and phosphatases involved are so numerous that bio-
chemical experiments dedicated to solve this issue are neces-
sary. If this process were to involve also constitutive vesicular 
dynamics a secondary dying-back event (Moreno et al., 2009) 
would results in the synaptic disconnection encountered in AD 
pathomorphology.
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function as shown in Figures 1B,D, 2, and 3C. This finding is 
highly significant, as it has been demonstrated that reduction of 
endogenous tau in an AD mouse model, ameliorates amyloid beta 
induced neurodegeneration at several levels (Roberson et al., 2007). 
Therefore, T-817MA has a potential to treat tau pathology. 
Addressing the mechanisms of T-817MA neuro-protection in rela-
tion to tau pathology remains to be elucidated. But the fact that both 
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